Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siji Antiviral Mixture for acute upper respiratory tract infection (common cold)
ChiCTR2300068364Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Siji Antiviral Mixture in nasopharyngitis and upper respiratory infection (URI) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Time to disappearance of all symptoms, Time to disappearance of individual symptoms and 7 more. Started Oct 2021; status: completed.
02
Drugs
Siji Antiviral Mixture
03
Conditions
nasopharyngitisupper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2300068364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068364.